MMTZF · MindMaze Therapeutics Holding SA
Market Cap
$66.59M
Shares
157.60M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
6.33M
-11%
FY2023
Net Income
-98.18M
-93.3%
FY2023
Operating Margin
-1751.39%
-1019.5pp
FY2023
Operating Cash Flow
-17.61M
+27%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| CHF | 6.33M | 7.11M | 4.49M |
| CHF | 1.33M | 12.39M | 19.02M |
| CHF | 5.39M | 7.75M | 6.75M |
| CHF | 3.32M | 3.86M | 2.04M |
| CHF | -110.83M | -52.04M | -34.31M |
| CHF | 949K | 2.29M | 1.32M |
| CHF | -111.68M | -54.32M | -35.53M |
| CHF | -13.5M | -3.53M | -820K |
| CHF | -98.18M | -50.79M | -34.71M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.